Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene
about
CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjectsRelation between viral fitness and immune escape within the hepatitis C virus proteaseStable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral FitnessInfluence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionSequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progressionEffects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation.Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolThe extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1.Vaccination against drug resistance in HIV infection.Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study.Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistanceInduction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.Immunization with HIV protease peptides linked to syngeneic erythrocytes.Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity.Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.
P2860
Q24798701-C3671007-EB81-4559-A748-D30012F7D082Q27478333-75BBB6A1-68CB-4186-8310-3CF732464588Q27486654-8B656E36-3391-4839-9D7C-15C8C2C147AFQ28480902-2241FB73-A5EA-4FF0-B5F2-E051740DFCB4Q33274640-55C112AC-F643-4E4C-A382-201B0B03894DQ33712891-92BC9CFD-80B6-4CE1-9CDD-C99ABA90E1F7Q34136227-57C2B28D-AA3D-4C3B-9309-2F1B94105FB5Q35090710-A6D43792-3575-4E13-BD41-D9FE010AA7D1Q35120811-F16987D1-9148-433C-B885-BD7CA129F3E2Q36099280-9657D207-65C4-4040-AD04-5DF44A846166Q36478181-F0AFE10F-1D14-4D4C-8BE2-8C42E975C748Q37077668-8C103AED-26EB-4C1E-A0F1-BF9B45BB3C70Q37325420-655BAA4C-8F33-4035-AC58-4470311D3906Q37351495-455A0180-507A-40C2-B3E4-A571FCB70542Q39280285-6F924E1A-8EEE-441D-8D6E-B0DC96CBCD12Q41913817-18C19F80-5B50-4830-8B66-20C1BB3BA8E9Q41950632-3DD23346-3A46-4ABF-B9B5-2C253140A4F6Q41966100-C3728563-A55E-4B4A-87F6-F1604F5C36D9Q42744528-3673C12C-81A5-414D-9A97-CC5EC40F75C1Q42797684-4C1EAC6F-C3F5-4DA7-8AB6-0A8BC0432813Q43578138-0F71808F-1893-4CB0-947F-95EE32453B9E
P2860
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@ast
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@en
type
label
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@ast
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@en
prefLabel
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@ast
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@en
P2093
P2860
P50
P1433
P1476
Dual pressure from antiretrovi ...... ncy virus type 1 protease gene
@en
P2093
Annika C Karlsson
Brandon D Heiken
Gabriel M Ortiz
James F Demarest
Jason D Barbour
Jeffrey N Martin
Matti Sällberg
Rebecca Hoh
Sophie R Younger
Teri Liegler
P2860
P304
P356
10.1128/JVI.77.12.6743-6752.2003
P407
P577
2003-06-01T00:00:00Z